Project Grant DP2OD040906
- This federal Project Grant award of $253,500.00 was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research conducted by the Icahn School of Medicine at Mount Sinai to investigate the relationship between mitochondrial dysfunction and the impact of non-syndromic autism spectrum disorder (ASD)-related risk genes on neuronal...
- This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $237,750 to the University of California, Merced to study the role of the BAF chromatin remodeling complex in experience-induced neuronal gene transcription and synapse maturation, with implications for autism spectrum disorders (ASD). The 2-year project aims to elucidate the functions of the SMARCC2 subunit of the BAF complex in regulating...
- This federal Project Grant award of $844,917 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to identify and characterize moderate effect size (MES) risk genes that contribute to Autism Spectrum Disorder (ASD) liability and manifestation. The key research objectives are to: (1) identify and characterize MES risk genes using rare and common genetic variation; (2) identify MES risk genes on Chromosome X; (3) identify MES risk...
- This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $194,375 to the University of Wisconsin-Madison to characterize the impact of midbody remnant-mediated genetic information transfer on cortical development in autism spectrum disorder (ASD). The research aims to elucidate how an ASD-associated PTEN mutation alters the molecular composition of midbody remnants (MBRs) and how MBR uptake...
- This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is focused on identifying novel noncoding genetic mechanisms that contribute to developmental disorders. The $499,055.48 award, with a project period from November 1, 2024 to October 31, 2027, will fund research led by Dr. Chelsea Lowther at the Icahn School of Medicine at Mount...
- This Project Grant awarded by the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to investigate how the gut microbiome composition impacts gastrointestinal (GI) and central nervous system (CNS) function in a mouse model of autism spectrum disorder (ASD). The $430,375 award to the partnership between Henry Ford Health and Michigan State University Health Sciences will...
- The U.S. National Institute of Neurological Disorders and Stroke (NINDS) awarded a $221,400 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Children's Hospital of Philadelphia (CHOP). This 5-year grant, beginning on August 1, 2025, aims to investigate the role of the c-Jun N-terminal kinase (JNK) signaling pathway in neurodevelopmental disorders (NDDs) such as autism and intellectual disability. The project will utilize...
- This Project Grant award of $241,380 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) aims to advance the understanding of neurodevelopmental disorders (NDDs) and develop innovative therapies. The research program, led by researchers at Boston Children's Hospital, will use single-cell epigenomic technologies to link pathogenic variants in chromatin regulators, such as...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund research to investigate the impact of coding and non-coding mutations in the ARID1B gene on neurodevelopmental disorders (NDDs). The $294,408 award, spanning November 2024 to May 2027, will enable Emory University to characterize ARID1B haploinsufficient mice at the...
- This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $421,047 to the University of Toledo to study the interaction between genetic and environmental risk factors for autism and other neurodevelopmental disorders. The key objectives are to investigate how developmental exposure to the pyrethroid pesticide deltamethrin interacts with a genetic mutation in the SHANK3 gene, which is associated with...
PLEIOTROPY OF AUTISM-ASSOCIATED CHROMATIN REGULATORS - ABSTRACT DESPITE TREMENDOUS SUCCESS IN THE RELIABLE IDENTIFICATION OF MORE THAN 100 GENES CARRYING LARGE RISK FOR AUTISM, AN ACTIONABLE UNDERSTANDING OF THE UNDERLYING BIOLOGY HAS BEEN ELUSIVE. GENE ONTOLOGY ANALYSES HAVE REPEATEDLY EMPHASIZED AN ENRICHMENT OF GENES ENCODING PROTEINS INVOLVED IN GENE EXPRESSION REGULATION AND NEUROTRANSMISSION. THESE AREAS HAVE THUS BECOME A CENTRAL FOCUS FOR THE FIELD. HOWEVER, ONTOLOGY-BASED ANALYSES RELY ON INCOMPLETE KNOWLEDGE OF GENE FUNCTION AND PLEIOTROPY, AND THEREFORE, HAVE THE POTENTIAL TO MISS KEY ASPECTS OF THE UNDERLYING BIOLOGY. INDEED, OUR RECENT FUNCTIONAL IN VIVO WORK HAS BEGUN TO ELUCIDATE ADDITIONAL ROLES FOR PROTEINS ANNOTATED AS CHROMATIN REGULATORS IN DIRECTLY REMODELING MICROTUBULES AND THE CYTOSKELETON. IN FACT, THERE EXISTS A "TUBULIN CODE" OF POST-TRANSLATIONAL MODIFICATIONS ANALOGOUS TO THE "HISTONE CODE" AND AMPLE EXAMPLES OF CANONICAL CHROMATIN MODIFIERS THAT DIRECTLY MODIFY TUBULIN TO REGULATE MICROTUBULE DYNAMICS. WE HAVE GENERATED PRELIMINARY DATA FOR FIVE SUCH AUTISM-ASSOCIATED CHROMATIN REGULATORS SUGGESTING THAT THEY HAVE DUAL FUNCTIONS, LOCALIZING TO AND FUNCTIONING AT MICROTUBULE-RICH STRUCTURES SUCH AS MITOTIC SPINDLES, NEURONAL GROWTH CONES, AND CILIA IN A WIDE VARIETY OF CELL TYPES, INCLUDING HUMAN NEURONS. THUS, WE HAVE DEVELOPED THE BOLD HYPOTHESIS THAT AUTISM-ASSOCIATED CHROMATIN REGULATORS HAVE DUAL FUNCTIONS REGULATING BOTH HISTONES AND TUBULINS. TO TEST THIS HYPOTHESIS, WE WILL DEPLOY INNOVATIVE EXPERIMENTS LEVERAGING UNIQUE ADVANTAGES OF THE XENOPUS EXPERIMENTAL TOOLKIT, COMPLEMENTED BY STATE-OF-THE-ART PROTEOMIC PROFILING OF TUBULIN POST-TRANSLATIONAL MODIFICATIONS IN HUMAN CELLS. IN DOING SO, THIS WORK WILL ILLUMINATE HOW HIGH-CONFIDENCE ASD-ASSOCIATED CHROMATIN REGULATORS FUNCTION AT MICROTUBULES AND THE UNDERLYING POST-TRANSLATIONAL MODIFICATIONS OF TUBULIN THAT MEDIATE THESE EFFECTS. THIS WILL SET THE STAGE FOR FUTURE WORK EXPLORING HOW THESE FUNDAMENTAL EFFECTS ON TUBULIN CASCADE TO INFLUENCE OTHER NEURONAL PROCESSES LIKE NEURONAL MIGRATION, AXON OUTGROWTH, DENDRITE FORMATION, SYNAPTOGENESIS, AND SYNAPTIC TRANSMISSION. THIS WORK HAS THE POTENTIAL TO COMPLETELY REFRAME THE POTENTIALLY RELEVANT FUNCTIONS OF THESE GENES TO AUTISM BIOLOGY, POTENTIALLY BRINGING TOGETHER THE SEEMINGLY DISPARATE ENRICHED ANNOTATIONS SINCE MICROTUBULE DYSFUNCTION IMPACTS NEUROTRANSMISSION. I AM UNIQUELY POSITIONED TO LEAD THIS PROJECT, LEVERAGING MY EXPERIENCE IN ASD GENETICS, PROTEOMICS, AND INNOVATIVE USE OF XENOPUS TO MODEL ASD GENE VARIANTS AND IDENTIFY CORE UNDERLYING BIOLOGY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1 | 9/18/25 |